This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamasawa, K. Articles by Itakura, M. Search for Related Content PubMed PubMed Citation Articles by Yamasawa, K. Articles by Itakura, M. Related Collections Commentary

Clinicopathological Significance of Abnormalities in Gadd45 Expression and Its Relationship to p53 in Human Pancreatic Cancer

First Department of Surgery, Shimane Medical University, Izumo, Shimane 693-8501, Japan

Purpose: The growth arrest and DNA damage-inducible 45 gene (GADD45a) is one of the downstream mediators of the p53 gene that stimulates DNA excision repair. The present study was designed to assess the clinicopathological significance of GADD45a and p53 in resectable invasive ductal carcinomas (IDCs) of the pancreas.

Experimental Design: This study included 72 pancreatic IDC patients who received surgery between 1982 and 2001. Point mutations in exons 1 and 4 of GADD45a and the expression of the GADD45a gene product (Gadd45) and p53 protein were analyzed by direct DNA sequencing and immunohistochemistry.

Results: Point mutations were found in exon 4 of GADD45a in eight cases (13.6%). Gadd45 and p53 were expressed in 54.2% (39 of 72) and 47.2% (34 of 72) of the patients. The expression of Gadd45 did not necessarily correlate with that of p53. However, Gadd45 expression correlated significantly with the grade of the pT factor of the tumors. Coexpression analysis of Gadd45 and p53 indicated that in patients with p53(+) IDC, the Gadd45(+) group had a significantly lower survival rate than the Gadd45(-) group. Furthermore, Gadd45 expression had no effect on the efficacy of the adjuvant chemotherapy. Multivariate analysis indicated that pTNM (tumor-node-metastasis) stage, grade, and adjuvant chemotherapy were significant variables for survival. Furthermore, in the p53(-) group, there were no significant variables. In contrast, in the p53(+) group, pTNM stage, histological grade, and Gadd45 expression were significant variables.

Conclusions: The frequency of GADD45a mutation is appreciable in human pancreatic IDC, and the expression of Gadd45, combined with that of p53, significantly affects the survival of patients with resectable IDCs of the pancreas.

Commentary

Gadd45a: An Elusive Yet Attractive Candidate Gene in Pancreatic Cancer : Commentary re: K. Yamasawa et al., Clinicopathological Significance of Abnormalities in Gadd45 Expression and Its Relationship to p53 in Human Pancreatic Cancer. Clin. Cancer Res., 8: 2563–2569, 2002

Jeffrey Hildesheim and Albert J. Fornace, Jr.
Clin. Cancer Res. 2002 8: 2475-2479. [Full Text] [PDF]

This article has been cited by other articles:

				S. P. Reddy, R. Britto, K. Vinnakota, H. Aparna, H. K. Sreepathi, B. Thota, A. Kumari, B.M. Shilpa, M. Vrinda, S. Umesh, et al. Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis Clin. Cancer Res., May 15, 2008; 14(10): 2978 - 2987. [Abstract] [Full Text] [PDF]

				A. S. Soliman, A.-C. Lo, M. Banerjee, N. El-Ghawalby, H. M. Khaled, S. Bayoumi, I. A. Seifeldin, A. Abdel-Aziz, J. L. Abbruzzese, J. K. Greenson, et al. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution Carcinogenesis, August 1, 2007; 28(8): 1794 - 1799. [Abstract] [Full Text] [PDF]

				L. F. Zerbini and T. A. Libermann GADD45 Deregulation in Cancer: Frequently Methylated Tumor Suppressors and Potential Therapeutic Targets Clin. Cancer Res., September 15, 2005; 11(18): 6409 - 6413. [Full Text] [PDF]

				D. V. Bulavin, O. Kovalsky, M. C. Hollander, and A. J. Fornace Jr. Loss of Oncogenic H-ras-Induced Cell Cycle Arrest and p38 Mitogen-Activated Protein Kinase Activation by Disruption of Gadd45a Mol. Cell. Biol., June 1, 2003; 23(11): 3859 - 3871. [Abstract] [Full Text] [PDF]

				J. Hildesheim, D. V. Bulavin, M. R. Anver, W. G. Alvord, M. C. Hollander, L. Vardanian, and A. J. Fornace Jr. Gadd45a Protects against UV Irradiation-induced Skin Tumors, and Promotes Apoptosis and Stress Signaling via MAPK and p53 Cancer Res., December 15, 2002; 62(24): 7305 - 7315. [Abstract] [Full Text] [PDF]

				C. H. Baker, D. Kedar, M. F. McCarty, R. Tsan, K. L. Weber, C. D. Bucana, and I. J. Fidler Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas Am. J. Pathol., September 1, 2002; 161(3): 929 - 938. [Abstract] [Full Text] [PDF]

				J. Hildesheim and A. J. Fornace Jr. Gadd45a: An Elusive Yet Attractive Candidate Gene in Pancreatic Cancer : Commentary re: K. Yamasawa et al., Clinicopathological Significance of Abnormalities in Gadd45 Expression and Its Relationship to p53 in Human Pancreatic Cancer. Clin. Cancer Res., 8: 2563-2569, 2002 Clin. Cancer Res., August 1, 2002; 8(8): 2475 - 2479. [Full Text] [PDF]